8-K: SelectQuote Reports Strong Q1 Fiscal 2025 Results, Raises Full-Year Guidance

SelectQuote's first quarter of fiscal year 2025 shows significant revenue growth and improved profitability, leading to an increased full-year outlook.

Summary

• SelectQuote reported a consolidated revenue of $292.3 million for the first quarter of fiscal year 2025, a 26% increase compared to $232.7 million in the same period last year.
• The company's net loss for the quarter was $44.5 million, compared to a net loss of $31.1 million in the first quarter of fiscal year 2024.
• Adjusted EBITDA for the quarter was $(1.7) million, an improvement from $(11.4) million in the prior year's first quarter.
• The company's Healthcare Services segment saw a 60% increase in revenue, reaching $155.7 million, and a 110% increase in Adjusted EBITDA to $4.9 million.
• SelectRx membership grew by 64% year-over-year, reaching 86,521 members.
• The company has raised its full-year fiscal 2025 guidance, now expecting revenue between $1.425 billion and $1.525 billion, net income (loss) between $(59) million and $3 million, and Adjusted EBITDA between $100 million and $130 million.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with strong revenue growth and improved profitability, but the net loss and negative Adjusted EBITDA temper the overall sentiment. The raised guidance and successful securitization are positive indicators.

Positives

• SelectQuote experienced significant revenue growth across its segments.
• The company's Adjusted EBITDA improved compared to the same quarter last year.
• The Healthcare Services segment showed strong growth in both revenue and Adjusted EBITDA.
• SelectRx membership saw substantial growth, indicating strong adoption of the service.
• The company successfully completed a $100 million securitization transaction, improving capital flexibility.
• The company has raised its full-year guidance for revenue, Adjusted EBITDA, and net income.

Negatives

• The company reported a net loss of $44.5 million for the quarter, which is higher than the $31.1 million loss in the same period last year.
• The company's Adjusted EBITDA was still negative at $(1.7) million, although an improvement year-over-year.
• Medicare Advantage approved policies decreased by 6% year-over-year.
• Term life premiums decreased by 16% year-over-year.

Risks

• The company relies on a limited number of insurance carrier partners, and the termination of these relationships could negatively impact the business.
• Changes in health insurance laws and regulations could affect the company's operations.
• Competition from other brokers and insurance carriers could impact market share.
• The company's financial results are subject to seasonality.
• The company's debt levels could impact future growth and profitability.
• The company is exposed to risks related to its pharmacy business, including supply chain disruptions and regulatory changes.

Future Outlook

SelectQuote has raised its full-year fiscal 2025 guidance, now expecting revenue between $1.425 billion and $1.525 billion, net income (loss) between $(59) million and $3 million, and Adjusted EBITDA between $100 million and $130 million.

Management Comments

• SelectQuote opened our fiscal 2025 with a strong quarter and our holistic approach to healthcare connectivity between Americans in need of care, and the insurers and caregivers that provide it, has never been more valuable.
• This quarter was also a success for our broadening Healthcare Services platform led by SelectRx.
• SelectQuote recently announced our initial receivable securitization, which was a critical first step in our ongoing strategy to improve our capital flexibility.

Industry Context

The report highlights the shift in benefit coverage for Medicare Advantage plans, indicating a dynamic market where SelectQuote's agent-led platform is gaining traction. The growth in SelectRx membership also reflects a broader trend towards integrated healthcare services.

Comparison to Industry Standards

• SelectQuote's revenue growth of 26% year-over-year is strong compared to some of its competitors in the insurance brokerage space, such as eHealth, Inc., which has seen more modest growth in recent quarters.
• The company's focus on a 'true-choice' model with agent-led support differentiates it from purely online brokers, such as GoHealth, Inc., which may not offer the same level of personalized service.
• The growth of SelectRx is notable, as it positions SelectQuote to compete with companies like CVS Health and Walgreens in the pharmacy services sector, although on a smaller scale.
• The securitization transaction is a positive step towards improving capital flexibility, which is crucial for companies in the financial services sector, and is similar to strategies employed by other companies to manage debt and improve liquidity.

Stakeholder Impact

• Shareholders will likely react positively to the increased revenue and raised guidance.
• Employees may benefit from the company's growth and improved financial position.
• Customers will continue to have access to a range of insurance and healthcare services.
• Insurance carrier partners will benefit from the company's ability to generate leads and sales.

Next Steps

• The company will share its AEP results next quarter.
• The company will continue to focus on improving capital flexibility.
• The company will continue to grow its Healthcare Services platform.

Key Dates

Keywords

SelectQuote, Insurance, Medicare Advantage, Healthcare Services, SelectRx, Adjusted EBITDA, Revenue, Financial Results, Securitization, Guidance